Marinomed Biotech AG earnings
Annual earnings per share (EUR per share, as reported)
| Fiscal year | Period end | Diluted EPS | Basic EPS | Filed |
|---|---|---|---|---|
| 2023 | 2023-12-31 | €-4500.00 | €-4500.00 | 2026-06-19T15:01:40Z |
| 2022 | 2022-12-31 | €-4300.00 | €-4300.00 | 2026-06-19T15:01:40Z |
Revenue & profit (EUR)
| Concept | 2023 | 2022 |
|---|---|---|
| Revenue | €9.2M | €11.3M |
| Profit for the year | -€6.8M | -€6.4M |
Methodology
Earnings per share comes from ifrs-full:DilutedEarningsLossPerShare /
ifrs-full:BasicEarningsLossPerShare; revenue from
ifrs-full:Revenue and profit from ifrs-full:ProfitLoss,
as tagged in Marinomed Biotech AG's ESEF annual reports (source:
filings.xbrl.org).
Figures are in EUR, as reported. Not investment advice.